XTANT MED HLDGS INC's ticker is XTNT and the CUSIP is 98420P308. A total of 20 filers reported holding XTANT MED HLDGS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,318 | +3.8% | 35,744 | -12.3% | 0.02% | +5.9% |
| Q2 2023 | $37,888 | +45.9% | 40,744 | 0.0% | 0.02% | +30.8% |
| Q1 2023 | $25,974 | -3.4% | 40,744 | 0.0% | 0.01% | -13.3% |
| Q4 2022 | $26,891 | -7.3% | 40,744 | 0.0% | 0.02% | -11.8% |
| Q3 2022 | $29,000 | +38.1% | 40,744 | 0.0% | 0.02% | +41.7% |
| Q2 2022 | $21,000 | -25.0% | 40,744 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $28,000 | – | 40,744 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,207,012 | $51,099,000 | 0.61% |
| Park West Asset Management LLC | 1,258,733 | $6,986,000 | 0.26% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $278,000 | 0.00% |
| Winslow, Evans & Crocker, Inc. | 1,258 | $8,000 | 0.00% |
| MORGAN STANLEY | 10,824 | $60,000 | 0.00% |
| BlackRock Inc. | 10,060 | $56,000 | 0.00% |
| Valeo Financial Advisors, LLC | 91 | $1,000 | 0.00% |
| Renaissance Technologies | 83,896 | $560,000 | 0.00% |
| BARCLAYS PLC | 390 | $2,000 | 0.00% |
| ROYAL BANK OF CANADA | 97 | $1,000 | 0.00% |